FDA Clearance Tracker · P100018-S034
Pipeline Vantage Embolization Device with Shield Technology
Last checked: Nov 20, 2026Latest source record: Sep 15, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 15, 2023
Approved
Time to decision
718 days
Received Sep 27, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100018-S034
- Device name
- Pipeline Vantage Embolization Device with Shield Technology
- Applicant location
- Irvine, CA
- Received
- Sep 27, 2021
- Decided
- Sep 15, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100018
Device type
- Device type
- Intracranial aneurysm flow diverter (OUT)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a new neurovascular flow-diverting stent and delivery system in the Pipeline product family.
Source documents
Other decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241388 · Decided Jan 2, 2025 · 232 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K243418 · Decided Dec 2, 2024 · 28 days after receipt
Device type: Apparatus, Suction, Ward Use, Portable, Ac-Powered (JCX) · General & Plastic Surgery
K243080 · Decided Oct 29, 2024 · 29 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.